T1	Participants 410 505	patients enrolled in the Primary Stenting of Totally Occluded Native Coronary Arteries II study
T2	Participants 515 793	Patients with totally occluded coronary arteries randomized to either sirolimus-eluting Cypher stents (SESs) (Cordis, a Johnson & Joshson Company, Miami Lakes, FL) (100 patients) or bare-metal BxVelocity stents (BMSs) (Cordis) (100 patients) were followed clinically for 3 years
T3	Participants 34 95	primary stenting of totally occluded native coronary arteries
T4	Participants 217 324	total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)
